Partnership includes the development of combination products, including a fixed-dose combination of petrelintide and Roche’s dual GLP-1/GIP receptor agonist, CT-388, for weight management.

Diet on Weight Loss and Cardiovascular Disease Risk Factors in Overweight and/or Obesity: A Systematic Review and Meta-Analysis,” published in the February 2025 issue of International Journal of ...

including but not limited to blood pressure control and hemoglobin A1c. And further underscoring our commitment to quality, 8 of Astrana's affiliate provider groups were recognized with the ...

His DM was controlled initially with diet and then recent addition of glipizide (heamoglobin A1c (HbA1c) 6.1). Patient did not have any history of diabetic retinopathy or nephropathy and baseline ...

A UK-based study develops and validates a five–drug class model that uses routine clinical data to identify optimal ...

About 1.22 million people have died of COVID in the U.S., CDC data shows. Tuesday marks five years since the World Health Organization (WHO) declared the global outbreak of COVID-19 to be a ...

This study presents a valuable finding on the importance of the plasma metabolome in glaucoma risk prediction. The authors have used the UK Biobank data to interrogate the association between plasma ...

KUALA LUMPUR -- Malaysia's economy expanded robustly in 2024 driven by resilient domestic demand and a recovery in exports, data showed on Friday, but the pace of growth eased in the final quarter ...

We studied the association of Hgb A1c levels with annual income, material and social deprivation in a Canadian primary care population. We found an inverse relationship between SES and Hgb A1c and ...